Can CYP1A1 siRNA be an effective treatment for lung cancer?

Cellular and Molecular Biology Letters

Volumn 13, Issue 2, 2008, Pages 240-249

  Mohammed, Kulthum ^a   Shervington, Amal ^a  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

CYP1A1; Gene knockdown; hTERT; siRNA; Transfection

Indexed keywords

CYTOCHROME P450 1A1; SMALL INTERFERING RNA; TELOMERASE; TERT PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; EMBRYO; HUMAN; HUMAN CELL; LUNG CANCER; MALE; PROTEIN EXPRESSION; UPREGULATION; CELL COUNT; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; METABOLISM; TUMOR CELL LINE;

CELL COUNT; CELL LINE, TUMOR; CELL SURVIVAL; CYTOCHROME P-450 CYP1A1; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LUNG NEOPLASMS; RNA, SMALL INTERFERING; TELOMERASE; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 51549121877     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-007-0050-x     Document Type: Article

References (27)

1. Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Klaus, W. and Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in mammalian cell culture. Nature 411 (2001a) 494-498.
2. Hannon, G.J. and Rossi, J.J. Unlocking the potential of the human genome with RNA interference. Nature 8S (2004) 431-371.
3. Wilda, M., Fuchs, U., Wossmann, W. and Borkhardt, A. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 37 (2002) 5716-5724.
4. Shammas, M.A., Koley, H., Batchu, R.B., Berheau, R.C., Protopopov, A., Muncshi, N.C. and Goyal, R.J. Telomerase inhibition by siRNA causes senescene and apoptosis in Barret's adenocarcinoma cells: mechanism and therapeutic potential. Mol. Cancer 4 (2005) 1-14.
5. Flynn, M.A., Casey, D.G., Todryk, S.M. and Mohon, B.P. Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo. J. Inflammation 1 (2004) 1-12.
6. Shervington, A., Mohammed, K., Patel, R. and Lea, R. Identification of a novel co-transcription of P450/1A1 with telomerase in A549. Gene 388 (2007) 100-117.
7. Guigal, N., Seree, E., Bourgarel-Rey, V. and Barra, Y. Induction of CYP1A1 by serum independent of AhR pathway. Biochem. Biophys. Res. Commun. 267 (2000) 572-576.
8. Iba, M.M., Scholl, H., Fung, J., Thomas, P.E. and Alan, J. Induction of pulmonary CYP1A1 by nicotine. Xenobiotica 28 (1995) 827-843
9. Guengerich, F.P. Forging the links between metabolism and carcinogenesis. Mutat. Res. 488 (2001a) 195-209.
10. Guengerich, F.P. Metabolism of chemical carcinogens. Carcinogenesis 21 (2000) 345-351.
11. Jean-Charles, S., Moon, C., Wang, L., Hittelman, W., Jang, S., Sun, S., Lee, J., Liu, D., Kurie, J., Morice, R., Lee, J., Hong, W. and Mao, L. Effects of N-(4-Hydroxyphenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers. J. Natl. Cancer Inst. 93 (2001) 1257-1263.
12. Hiyama, K. and Hiyama, E. Detection of telomerase activity in lung cancer tissues. Methods Mol. Med. 74 (2003) 401-412.
13. Xinarianos, G. Telomerase activity in non-small cell lung carcinomas correlates with smoking status. Int. J. Oncol. 15 (1999) 961-965.
14. Albanell, J., Lonardo, F., Rusch, V., Engelhardt, M., Langenfeld, J., Han, W., Klimstra, D., Venkatraman, E., Moore, M.A. and Dmitrovsky, E. High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. J. Natl. Cancer Inst. 89 (1997) 1609-1615.
15. Chi, J., Chang, N.Y., Wang, N.N., Chang, D.S., Dunphy, N. and Brown, P.O. Genome wide view of gene silencing by small interfering RNAs. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 6343-3646.
16. Ambion Inc. siRNA Target Finder. http://www.ambion.com/techlib/misc/ siRNA.
17. Lekas, P., Tin K, L., Lee, C. and Prokipcak, R.D. The human cytochrome P450 1A1 mRNA is rapidly degraded in HepG2 cells. Arch. Biochem. Biophys. 3849 (2000) 311-318.
18. Nemoto, N. and Sakural, J. Increase of CYP1A1 mRNA and AHH activity by inhibitors of either protein or RNA synthesis in mouse hepatocytes in primary culture. Carcinogenesis 12 (1991) 2115-2121.
19. Harley, G.B., Futcher, A.B. and Greidea, C.W. Telomerase shorten during aging of human fibroblast. Nature 345 (1990) 458-460.
20. Shay, J.W. and Roninson, J.B. Hallmarks of senescence in carcinogensis and cancer therapy. Oncogene 12 (2004) 2919-2933.
21. Hukkanen, J., Lassila, A., Paivarinta, K., Valanne, S. and Sarpo, S. Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line. Am. J. Respir. Cell Mol. Biol. 22 (2000) 360-366.
22. Liu, W., Zhang, Y., Shen, Y., Jiang, J., Miao, Z. and Ding, J. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells. Biochem. Biophys. Res. Commun. 323 (2004) 660-667.
23. Rossi, M.J. Inhibition of telomerase activity by ceramide in A549 human lung adenocarcinoma cells. Mol. Med. J. 2000 (2000) 1-5.
24. Pratt, W. and Toft, D. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp. Biol. Med. 228 (2004) 111-133.
25. Carver, L.A., Jackiw, V. and Bradfield, C.A. The 90-kDa heat shock protein is essential for Ah receptor signaling in a yeast expression system. J. Biol. Chem. 269 (1994) 30109-30112.
26. Holt, S.E., Aisner, D.L., Baur, J., Tesmer, V.M. and Dy, D. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev. 13 (1999) 817-826.
27. Chang, S. and DePinho, R.A. Telomerase extracurricular activities. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 12520-12522.